Actis Dato S M, Rebolledo O R
Centro de Endocrinología Experimental y Aplicada (CENEXA, UNLP-CONICET), Facultad de Ciencias Médicas, Universidad Nacional de La Plata, Argentina.
Medicina (B Aires). 2000;60(5 Pt 1):645-56.
Chronic hyperglycemia induces an increase in the non enzymatic glycation of circulating and structural proteins together with a glucose-generated oxidative and carbonyl stress, known as glycoxidation. The physicochemical characteristics and the metabolism of lipoproteins are altered by glycation/glycoxidation and resemble those of other body proteins, except for the fact that there is a simultaneous glycoxidation of both protein and phospholipid components generating an oxidative stress that increases lipoxidation. Information gathered during the last few years suggests that, among lipoproteins, modified LDL would principally contribute to developing diabetic micro-macrovascular complications. The control and the prevention of the progress of such complications are difficult to attain due to the irreversibility of glycoxidation. As glycation/glycoxidation is related to mean blood glucose, the goal in diabetes treatment must be the achievement of a close to normal metabolic control. This review summarizes advances in the importance of lipoprotein glycation/glycoxidation in diabetes mellitus.
慢性高血糖会导致循环蛋白和结构蛋白的非酶糖基化增加,同时产生葡萄糖诱导的氧化应激和羰基应激,即糖氧化应激。糖基化/糖氧化应激会改变脂蛋白的物理化学特性及其代谢,这与其他身体蛋白相似,但不同的是,脂蛋白的蛋白质和磷脂成分会同时发生糖氧化应激,进而产生增加脂质氧化的氧化应激。过去几年收集的信息表明,在脂蛋白中,修饰的低密度脂蛋白(LDL)是导致糖尿病微血管和大血管并发症的主要因素。由于糖氧化应激具有不可逆性,因此难以控制和预防此类并发症的进展。由于糖基化/糖氧化应激与平均血糖水平有关,糖尿病治疗的目标必须是实现接近正常的代谢控制。本文综述了脂蛋白糖基化/糖氧化应激在糖尿病中的重要性研究进展。